1. Management of spasticity in children with cerebral palsy Part I

Management of Spasticity in Children with Cerebral Palsy 

This continuing medical education presentation will address an integrated approach to the management of spasticity in the pediatric patient with cerebral palsy.

The educational objectives of this CME initiative are to:

• Outline the pathophysiological basis of cerebral palsy and the resultant abnormalities of neuromuscular function.
• Describe techniques to assess the anatomic and functional impairments of patients with cerebral palsy
• Discuss the pharmacological, surgical and rehabilitative approaches to improving the function and quality of life in patients with cerebral palsy.
• Identify the benefits, side effects and complications of treatment of muscle overactivity and spasticity in patients with cerebral palsy. 

Section Index

1. Management of spasticity in children with cerebral palsy Part I
2. Management of spasticity in cerebral palsy Part II Passive and Active Examination
3. Management of spasticity in cerebral palsy Part III Treatment of Patients with cerebral palsy and spasticity
4. Management of spasticity in cerebral palsy Part IV - Rehabilitation Management
5. Oral Medications for the Treatment of Spasticity
6. Intrathecal Baclofen for Spasticity in Cerebral Palsyy
7. Local Anesthetics, Neurolytics, and Chemodenervation for the Patient with Cerebral Palsy and Spasticity
8. Management of spasticity in cerebral palsy Part VIII -Botulinum Toxin
9. Neurosurgical Interventions for Spasticity in Children with Cerebral Palsy
10. Orthopedic Interventions for Spasticity in Children with Cerebral Palsyy
11. Management of spasticity in cerebral palsy Part XI-Alternative Medicine in Spasticity Management
12. Management of spasticity in cerebral palsy Part XII Case Studies
    
13. Management of spasticity in cerebral palsy Part XIII Document Downloads
14. Self Assessment

Disclaimer: The material presented in this course represents the clinical experience of the faculty, as well as current information obtained from the literature and includes discussions of off-label indications for various agents used to treat spasticity and muscle overactivity in children with cerebral palsy.